CONCLUSION
Biguanides, especially metformin, have a cardiovascular pharmacological,
immunomodulatory, antiviral and antioxidant effect, thus, they are a
potential therapeutic tool supporting the treatment of COVID-19. Thus,
experimental studies are necessary to confirm its effects in relation to
SARS-CoV-2 and the clinical evolution of the disease.